-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
When SpaceX's CRS-21 arrives at the International Space Station this weekend, it will carry several experiments to the International Space Station in addition to resupplying astronauts and the station.
, including the first COVID-19 drug experiment set up in space.
Scientists will use the commercial ICE Cubes Service to test coVID-19 drugs in microgravity to better understand how Redsyvir interacts with its delivery substance, cyclodext, to improve the drug's efficiency, according to the European Space Agency's official website.
it is understood that Redsyvir is an intravenous drug and that the experiment will not allow astronauts to receive any treatment.
will be the first COVID-19-related study to be carried out on the International Space Station.
," ESA said.
so far, there is still no broad consensus on whether Redsiwell is effective.
In October, just a week after WHO announced that drugs such as redsivir and hydroxychloroquine were "almost ineffective" in reducing the death rate from neocosmic pneumonia, the FDA officially approved Gilead's antiviral drug Veklury (remdesivir) for use in adults and children aged 12 and older who need hospitalization for at least 40 kg of COVID-19 treatment.
, the drug trial of Redsyvir is still ongoing, even as the controversy continues.
it is understood that the Redsiway space experiment will take place at ESA's Columbus laboratory, a module on the International Space Station that carries scientific and physical research.
InnoStudio, one of the experiment's customers, said in a statement in November that the team behind Redsivir's study on the International Space Station hopes it will make the drug more effective and reduce the risk of kidney problems in patients with kidney problems.
Network Source: Web Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Metz Medical and are not reproduced by any media, website or individual without authorization, and must be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
at the same time reproduced content does not represent the position of this site.
leave a message here
